Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.
Retroviral late (L) domains present within Gag act in conjunction with cellular proteins to efficiently release virions from the surface of the cell. Three different critical core sequences have been identified as required elements for L-domain function: PPPY, PTAP (also PSAP), and YPDL, with different retroviruses utilizing one or two of these core sequences. The human immunodeficiency virus type 1 (HIV-1) L domain is centered around a PTAP sequence in the p6 region of Gag. To assess the ability of heterologous L-domain sequences to be functionally interchanged for those in full-length HIV-1, we produced a series of constructs that replaced PTAP-containing p6(Gag) sequences with those of PPPY- or YPDL-based L domains. While previous studies had found that L domains are interchangeable in other retroviruses, most of the sequences introduced into p6(Gag) failed to substitute for PTAP-mediated L-domain function. One exception was the 11-amino-acid p2b sequence of Rous sarcoma virus (RSV) Gag, which could fully restore HIV-1 budding, while a PPPPY sequence exchange alone did not. This suggests that the RSV L domain consists of more than simply its core L-domain sequence. The HIV-p2b chimera was as infectious as the wild type, produced normal virions, and was sensitive to proteasome inhibitors. These results show that L-domain sequences are not necessarily interchangeable. Thus, HIV-1 Gag might have a more stringent requirement for L-domain function than the other retroviruses previously studied.
Ott
David E
DE
Basic Research Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland 21702-1201, USA. ott@ncifcrf.gov
Coren
Lori V
LV
Gagliardi
Tracy D
TD
Nagashima
Kunio
K
D000595:Amino Acid Sequence; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D015683:Gene Products, gag / Q000737:chemistry* / Q000502:physiology; D015497:HIV-1 / Q000737:chemistry / Q000502:physiology*; D006367:HeLa Cells; D006801:Humans; D061988:Proteasome Inhibitors; D014771:Virion / Q000502:physiology
D015853:Cysteine Proteinase Inhibitors; D015683:Gene Products, gag; D061988:Proteasome Inhibitors